Product
KIO-101
Aliases
DHODH inhibitor
1 clinical trial
1 indication
Indication
Dry Eye SyndromeClinical trial
A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune DiseaseStatus: Terminated, Estimated PCD: 2024-01-09